Pregnancy is accompanied by a lengthy list of do's and don'ts—take prenatal vitamins, no alcohol, exercise carefully, and eat well. But what about when an unplanned health issue presents itself, such as the necessity for a mammogram? For most women, this might not even be something they think about until they are in a position where breast cancer screening is an option.

Perhaps you're over 40 and in need of your yearly mammogram, or perhaps you have a history of breast cancer in your family and you want to keep your screenings current. More emergently, you've found a lump in your breast. So, can you have a mammogram when pregnant? The answer is yes, but there are several things to consider.

Pregnancy creates substantial hormonal changes that affect the body, as well as breast tissue. Estrogen and progesterone's rise causes the breasts to expand and condition to produce milk, which results in denser tissue. This increased density is more challenging to detect any abnormalities with using mammograms. Even post-delivery, should the woman be breastfeeding, milk-filled glands can also make the breasts denser and, as a result, make mammogram readings less clear.

While 3D mammograms have improved imaging technology to help navigate dense breast tissue, doctors often suggest postponing routine screening mammograms until after pregnancy if there are no symptoms or high-risk factors. However, if a lump or abnormality is found, your doctor may recommend immediate diagnostic imaging.

When Is a Mammogram Necessary During Pregnancy?

Mammograms are not done routinely if a woman becomes pregnant, yet there are specific situations where one might be unavoidable. Breast cancer in pregnancy does occur—1 in 3,000 times—but it's not common. If a lump is detected by a woman, she has constant breast pain and no explanation, or she is at high risk (e.g., strong history of breast cancer in her family or genetic defect such as BRCA1 or BRCA2), a physician will order a mammogram.

The process itself takes very little radiation exposure. The radiation employed by a mammogram is concentrated on the breast, and there is little to no radiation that reaches other areas of the body. A lead apron is also placed over the belly to shield the unborn child.

Alternative Breast Imaging Options During Pregnancy

For pregnant women requiring breast imaging, physicians may initially suggest an ultrasound. In contrast to a mammogram, an ultrasound is not done with the use of radiation and is deemed safe for pregnant women.

An ultrasound of the breast can establish whether a lump is a fluid-filled cyst or a solid tumor that needs further investigation. Yet ultrasounds are not always diagnostic, and in certain instances, a mammogram or biopsy is needed to determine or rule out cancer.

Magnetic Resonance Imaging (MRI) is also an imaging choice but has some drawbacks. The majority of breast MRIs employ a contrast material called gadolinium, which is able to pass through the placenta and to the fetus. Although risks are not entirely clear, physicians usually do not use MRI with contrast unless necessary. Some practitioners may offer an MRI without contrast as an option.

What If You Find a Lump In Your Breast During Pregnancy?

Breast changes throughout pregnancy are normal, but finding a lump should never be taken lightly. If you notice a lump, alert your medical provider right away. They will conduct a clinical breast exam and potentially have you get an imaging study such as an ultrasound or mammogram to see whether anything needs to be done.

If imaging indicates a suspicious mass, a biopsy can be suggested. Core needle biopsy is the most frequently used and is safe during pregnancy. It consists of numbing the skin with local anesthetic and inserting a hollow needle into the area to obtain a small sample of tissue to be tested.

Breast Cancer Treatment During Pregnancy

In the extremely uncommon event of a diagnosis of breast cancer while pregnant, therapy will be determined by the nature and extent of cancer and by how far along in pregnancy one is. The most frequent form of treatment is surgery—either mastectomy (surgical removal of the entire breast) or lumpectomy (surgical removal of the lump)—which is usually safe while pregnant.

Chemotherapy is also possible but usually only attempted after the first trimester, when it can damage developing fetal tissue. Radiation therapy is not used during pregnancy and is typically deferred until after giving birth. Hormonal therapy and targeted therapies are also omitted until after giving birth.

Can I Get a Mammogram While Breastfeeding?

Yes, you can have a mammogram while you are breastfeeding. The radiation in a mammogram does not impact breast milk or hurt the baby. But breast density is still high during lactation, and this might complicate detection of abnormalities. To enhance image quality, physicians usually advise breastfeeding or pumping 30 minutes prior to the mammogram.

Routine screening mammograms are usually delayed in pregnancy unless there is a high-level concern.

If a lump is detected, an ultrasound is typically the initial imaging study done, with a mammogram being a consideration if additional assessment is necessary.

• Pregnancy mammograms utilize minimal radiation and are safe when required.
• Breast MRI with contrast is usually avoided in pregnancy.
• Breast biopsy, when necessary, is safe during pregnancy.

If breast cancer does develop during pregnancy, there are available treatment options that can be adjusted to keep the mother and infant safe.

Pregnancy is a period of significant change, and health issues particularly those involving breast health, are anxiety-provoking. Routine mammograms are typically postponed until after giving birth, but diagnostic testing can be done if necessary. The best you can do is discuss changes you notice in your breasts with your healthcare provider in an open manner. Early detection and prompt treatment can make a very big difference in the health of both mother and fetus.

In June 2025, 337 ton of toxic waste from the Union Carbide factory in Bhopal finally left from the city in 12 trucks and arrived at the Pithampura industrial area. The waste was carried in spill-free trucks, but the impact of this toxic waste and the toxic gas on people, still spills today.

As we observe the National Pollution Control Day today, which commemorates the victims of the 1984 Bhopal Gas Tragedy, we also look back onto how its spill on human lives.

What Happened On December 2 and 3, 1984?

Between December 2 and 3, around midnight, in 1984, there was a massive leak of a poisonous chemical methyl isocyanate (MIC) from a Union Carbide pesticide plant that took thousand lives, and maimed a thousand more, leaving many, even four decades later, impacted.

As per the 1992 study by R Dhara, the gas leak caused chronic inflammatory damage to the eyes and lungs, which was also the main cause of morbidity. Reproductive health problems in form of increased spontaneous abortions and psychological problems were also reported.

The leak was called world's worst industrial disaster. Around 40 ton of toxic methyl isocyanate gas was released into air, and killed more than 3,000 people.

Those Who Are Still Affected

The toxic waste which had been lying till June this year, as per surveys, contain 6 of the persistent organic pollutants that are banned by the United Nations for their highly poisonous impacts on the environment and human health.

As per the data by the Sambhavna Trust, even after 3 decades, the mortality rate for gas-exposed victims is still 28% higher than the average. The survivors are twice as likely to die of cancers, lung diseases, and tuberculosis. They are also three times as likely to die from kidney diseases and 63% more likely to have illnesses. The data also showed that a 25% of the survivors who had been exposed to the gas were under-active thyroid and can have long-term health impacts.

The explosion also had adverse effects on women, babies, and caused a high rate of infertility, stillbirths, abortions, early menopause and irregularities in menstrual cycles. The Guardian reported that many women left their husbands as they believed "not to be capable of fulfilling the familial duties expected of them".

The Chingari Children's Centre which was established for those born with disabilities due to the gas tragedy registered over 1,000 children. Many of these kids were affected by cerebral palsy, muscular dystrophy, autism, intellectual disabilities, and severe learning difficulties.

A study by the Indian Council for Medical Research (ICMR), found that still 9% of babies who were born between 2016-17 had birth defects. These babies were born to mothers who had been exposed to gas. The Guardian reports that the "study was subsequently discredited by the ICMR, who ordered it not to be published or disclosed."

The Leak That Leaks Even Today

Last year, in September, survivors of the tragedy also visited Harvard TH Chan School of Public Health and shared their stories. The survivors included two women who were children when the gas leak happened, Farhat Jahan and Bati Bai Rajak. They shared that the disaster still continues to leave its impact on the new generation.

A 2023 study published in journal BMJ One also revealed that even after four decades of the tragedy, future generations are afflicted by disabilities and cancer. The study also noted a decline in male births a year after the tragedy, impacting around 100km radius around Bhopal.

Other health conditions include respiratory, neurological, musculoskeletal, ophthalmic, and endocrine issues. The impact also resulted in a 4-fold increase in miscarriages and a higher risk of stillbirth. Researchers from the University of California San Diego also noted that reproductive health impacts could trickle town to future generations, which could be seen even today.

Gordon McCord from the School of Global Policy and Strategy at UC San Diego and the author of the study said that male fetuses are more suspectable to adverse shocks including smog, disease, natural disasters and stressful events during pregnancy. This was reported in media outlet Down To Earth.

Studies also found that men born in 1985 within the 100 km of Bhopal had eight-fold increased risk of cancer.

Another study which analyzed the survivors from 1985 to 1994, titled Health Effects of the Toxic Gas Leak from the Union Carbide Methyl Isocyanate Plant in Bhopal noted for genetic risk of pregnancy outcome in women who were exposed to the toxic gas. The abortion rate was 523 per 1000, immediately after the tragedy. The study also found that infants were born with congenital malformations.

Bhopal gas leak tragedy paved way for a safer workspace and lead to the many laws which aims to protect the survivors, their rights, and also holds the companies accountable for the damage. However, despite this, many survivors still continue to live with chronic pain, diseases, and scarred memories from the tragedy.

This day observed as the National Pollution Control Day is a reminder to why environmental safety is key to health safety, and must alarm the nation for the air pollution situation that continues to worsen by every passing day.

Lots of new developments around weight-loss drugs, with the World Health Organization now stepping in to lower the dosage, and many companies like Eli Lilly actually slashing down the price for better access. Amid this what people may be forgetting are the unusual side effects of being on popular weight loss drugs.

The internet has made room for a lot of unusual confessions, but few are as chaotic, or as oddly supportive, as the Reddit threads where people taking weight-loss jabs like Ozempic and Wegovy openly discuss their most embarrassing side effects. And one theme keeps popping up: unpredictable bowel movements, including the dreaded “sleep sh*ts.”

One Reddit user started a viral thread with a painfully honest plea: “Any advice for not sh*tt*ng in the bed while sleep?” The user said they’d been dealing with this for months and called it “the most annoying side effect.” Another person, already three shots in, nervously listed “sh*tt*ng the bed” as something they were “not looking forward to.”

This mix of diarrhea, constipation, and everything in between has sparked concern, and, for many, shame. But as more people turn to GLP-1 medications for weight loss, understanding why this happens has never been more important.

Also Read: Ozempic Stomach: Why Ozempic Consumers Are Suing This Popular Weigh-loss Drug For 2 Billion Over Stomach Paralysis

Pooping Uncontrollably: It Happens More Often Than You Think

The phenomenon isn’t limited to anonymous Reddit users. A Florida nurse, interviewed by Business Insider, described weeks of constipation so bad she tried “everything from stool softeners to a megadose of Milk of Magnesia.” But by attempting to “hit it from the top and bottom,” she ended up losing control altogether, hence her reluctant membership in the self-appointed “sh*t the bed club.”

Another semaglutide user confessed online: “I quite literally sh*t myself while sleeping… tough few days of diarrhea after my first injection.” And yet, others reported the opposite: stubborn constipation, going days without relief, or passing what one Redditor bluntly called “rocks.”

These extremes highlight one thing clearly, digestive unpredictability is surprisingly common.

Why Do GLP-1 Drugs Mess With Your Gut?

Semaglutide (the active ingredient in Ozempic and Wegovy) is part of a class of medications called GLP-1 receptor agonists. These drugs work by slowing gastric emptying and nutrient absorption so users feel full for longer. But the same mechanism that makes the drugs effective can also confuse the digestive system.

Medical News Today notes that Ozempic often triggers a “stool reflex”, when food entering the gut prompts the colon to clear space. For some people, this reflex becomes unusually strong or overactive, leading to diarrhea.

On the flip side, slowing the gut too much can cause constipation. That’s why Wegovy’s own prescription info reports both diarrhea (30% of users) and constipation (24% of users) during clinical trials.

New York gastroenterologist Dr. Eric Goldstein told Insider that while digestive issues are a known side effect of GLP-1 drugs, the severity seen in social media posts is likely exaggerated because people tend to share the worst-case scenarios. Still, he emphasised that “any medication… may have changes or side effects that need to be monitored.”

How Long Does It Last — And Should You Be Worried?

Fortunately, most people don’t deal with weeks of chaos. According to 2022 research, Ozempic-related diarrhea typically lasts around three days after starting treatment. For the majority, symptoms settle within the first four weeks as the body adjusts. Only 4.3% of people stopped treatment because of GI side effects.

However, flare-ups are common after dose increases, and doctors may recommend slowing dose escalation or adjusting timing if symptoms become disruptive.

Still, experts consistently advise the same thing Reddit does, though with less sarcasm: monitor your symptoms, stay hydrated, avoid greasy or heavy foods, and reach out to your doctor if things become severe or last longer than a few weeks.

The World Health Organization (WHO) has warned that not enough weight loss jabs will be left for those who need it. While weight loss drugs offer a great potential to tackle the obesity issue that is on the rise, globally. However, the accessibility to those who actually need it is fewer than 1 in 10 people.

Worldwide, there are one billion obese people, and are the ones calling for widespread and fairer access to these GLP-1 medication. Health prediction says that by 2030, more than two billion people will be obese unless action is taken seriously.

However, the limited production of the GLP-1 medication, high costs, and supply chain constraints have become a barrier to its universal access. WHO has already added the GLP-1 medication to its 'essential' medicines list for overweight patients with diabetes that countries are advised to provide.

"Our new guidance recognises that obesity is a chronic disease that can be treated with comprehensive and lifelong care. While medication alone won't solve this global health crisis, GLP-1 therapies can help millions overcome obesity and reduce its associated harms," says WHO director-general Tedros Adhanom Ghebreyesus.

As per WHO, these drugs represent a new chapter in how society approaches obesity from a lifestyle condition to a complex, preventable, and treatable chronic disease. It says these drugs can be used long-term, for six months or more, but they should be prescribed together with guidance on diet and exercise to help people maintain their weight loss. The problem is only few people can actually access them. "Our greatest concern is equitable access," says Tedros.

Also Read: Eli Lilly's Popular Weight Loss Zepbound Price Goes Down, Now More Accessible

How Short Are We On Skinny Jabs?

As of now, WHO notes that under the present scenario of GLP-1 therapies, only 100 million people could benefit them, which is less than 10% of those who need them.

WHO's latest guidelines are now calling on countries and companies to expand access, through strategies and voluntary licensing. This means companies can grant permission for others to make affordable non-brand versions of its patented drug.

A patent on semaglutide, the main ingredient in Novo Nordisk’s Wegovy, is set to expire in many countries in 2026. Once that happens, other manufacturers will be able to produce and sell cheaper versions in markets such as India, Canada, China, Brazil and Turkey.

The WHO also says countries need to build healthier environments that support good health and help prevent obesity.

How Do GLP-1 Medications Work?

GLP-1 drugs mimic the action of the natural hormone GLP-1 to regulate blood sugar and promote weight loss. They work by increasing insulin release in a glucose-dependent manner, decreasing the liver's production of glucagon, and slowing down the emptying of the stomach, which helps lower blood sugar levels after a meal. They also act on the brain to suppress appetite and increase feelings of fullness, leading to reduced calorie intake.

In people with type 2 diabetes, notes Harvard Health, the body's cells are resistant to the effects of insulin and body does not produce enough insulin, or both. This is when GLP-1 agonists stimulate pancreas to release insulin and suppress the release of another hormone called glucagon.

These drugs also act in the brain to reduce hunger and act on the stomach to delay emptying, so you feel full for a longer time. These effects can lead to weight loss, which can be an important part of managing diabetes.